Physician profile

Ross Zafonte

Brain Injury Medicine (Physical Medicine & Rehabilitation) · Columbia, MO

NPI 1871569145

$51,875.00

in general payments reported to CMS, 2019-2025

2 companies · $7,500 in 2025

The $7,500 reported for 2025 was more than what 90% of Brain Injury Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $165).

See the full distribution for Brain Injury Medicine (Physical Medicine & Rehabilitation)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$21,875.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Myomo, INC $51,875.00 2019-2025

1 company reported research payments only; those appear in the research section below.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ross Zafonte

$51,875.00

in general payments reported 2019-2025

Years
2019-2025
Top company
Myomo, INC
Context
The $7,500 reported for 2025 was more than what 90% of Brain Injury Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $165).

https://glasscript.com/doctor/1303950/ross-zafonte

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.